Skip to main content
    C

    Community Health Systems Inc (CYH)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $2.12
    -0.12 (-5.36%)

    Market Cap: $315.90M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Community Health Systems Inc (CYH) Earnings: Report Dates and Results

    Updated Oct 28, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Community Health Systems (CYH) is expected to report earnings on Feb 16, 2027. In the quarter ended Sep 30, 2026, Community Health Systems reported EPS of -$0.48, below the -$0.22 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    57%(21/37)
    Avg Surprise
    +15.45%

    Upcoming Estimates

    Reports Feb 16, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.02
    Range-$0.35 - $0.42
    10 analysts
    Revenue Consensus
    $2.83B
    Range$2.70B - $3.00B
    9 analysts
    Reports Apr 19, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.32
    Range-$0.39 - -$0.26
    3 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago-$0.17-91.9%
    60d ago-$0.16-104.3%
    30d ago-$0.19-69.6%
    7d ago-$0.19-69.6%
    Current-$0.32
    Revenue Consensus
    $2.74B
    Range$2.70B - $2.81B
    3 analysts

    Next Report

    CYH has an expected report date of Feb 16, 2027.

    CYH Earnings Call

    The latest CYH earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 37 quarters below that had an estimate, CYH beat 21, missed 15 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $2.76B, down 10.7% from $3.09B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.48-$0.22N/A-118.18%Miss-137.8%50 up, 4 downOct 28, 2026$2.76B
    Jun 30, 2026-$0.19-$0.18-$0.32 - $0.00-5.56%MissN/A74 up, 1 downJul 22, 2026$2.83B
    Mar 31, 2026-$0.48-$0.05-$0.26 - $0.11-860.00%MissN/A60 up, 0 downApr 21, 2026$2.96B
    Dec 31, 2025$0.80-$0.32-$0.35 - $0.41+350.91%BeatN/A60 up, 5 downFeb 18, 2026$3.11B
    Sep 30, 2025$1.27-$0.28-$0.48 - -$0.18+553.57%BeatN/A60 up, 1 downOct 23, 2025$3.09B
    Jun 30, 2025-$0.05-$0.10-$0.32 - -$0.03+50.00%BeatN/A80 up, 1 downJul 23, 2025$3.13B
    Mar 31, 2025-$0.03-$0.10-$0.17 - -$0.05+70.00%BeatN/A80 up, 1 downApr 23, 2025$3.16B
    Dec 31, 2024-$0.42-$0.06-$0.69 - $0.07-663.64%MissN/A70 up, 1 downFeb 18, 2025$3.26B
    Sep 30, 2024-$0.30-$0.18-$0.29 - -$0.02-66.67%MissN/A80 up, 0 downOct 23, 2024$3.09B
    Jun 30, 2024-$0.17-$0.12-$0.15 - -$0.07-41.67%MissN/A80 up, 0 downJul 24, 2024$3.14B
    Mar 31, 2024-$0.14-$0.14-$0.21 - -$0.070.00%In lineN/A80 up, 0 downApr 24, 2024$3.14B
    Dec 31, 2023-$0.41$0.06$0.01 - $0.12-783.33%Miss-127.3%70 up, 0 downFeb 20, 2024$3.18B
    Sep 30, 2023-$0.33-$0.16-$0.23 - -$0.10-106.25%MissN/A70 up, 2 downOct 25, 2023$3.09B
    Jun 30, 2023-$0.22-$0.26-$0.37 - -$0.13+15.38%BeatN/A91 up, 0 downAug 2, 2023$3.12B
    Mar 31, 2023-$0.43-$0.16-$0.43 - -$0.01-168.75%Miss-407.1%90 up, 1 downMay 1, 2023$3.11B
    Dec 31, 2022$1.50$0.37-$0.23 - $1.19+305.41%Beat+30.4%90 up, 0 downFeb 15, 2023$3.14B
    Sep 30, 2022-$0.52-$0.02-$0.61 - $0.43N/AN/A-175.4%100 up, 0 downOct 26, 2022$3.02B
    Jun 30, 2022-$2.52$0.05-$0.27 - $0.24N/AN/A-1195.7%100 up, 1 downJul 27, 2022$2.93B
    Mar 31, 2022$0.14$0.10-$0.06 - $0.40+40.00%Beat-61.1%70 up, 0 downApr 27, 2022$3.11B
    Dec 31, 2021$1.15$0.61$0.14 - $0.62+88.52%Beat+19.8%110 up, 0 downFeb 16, 2022$3.23B
    Sep 30, 2021$0.69$0.12-$0.06 - $0.40+475.00%Beat+283.3%100 up, 0 downOct 27, 2021$3.12B
    Jun 30, 2021$0.23$0.01-$0.13 - $0.10N/AN/A-72.9%10N/AJul 28, 2021$3.01B
    Mar 31, 2021$0.36-$0.16-$0.37 - $0.12+325.00%BeatN/A10N/AApr 28, 2021$3.01B
    Dec 31, 2020$0.96$0.20-$0.52 - $1.26+380.00%Beat+140.0%11N/AFeb 17, 2021$3.72B
    Sep 30, 2020$0.18-$0.11-$1.00 - $1.32+263.64%BeatN/A11N/AOct 27, 2020$3.13B
    Jun 30, 2020$0.85-$0.83-$2.01 - $0.26+202.41%BeatN/A9N/AJul 28, 2020$2.52B
    Mar 31, 2020-$1.59-$0.58-$1.18 - -$0.22-174.14%MissN/A13N/AApr 28, 2020$3.02B
    Dec 31, 2019$0.40-$0.46-$0.77 - -$0.11+186.96%BeatN/A13N/AFeb 19, 2020$3.29B
    Sep 30, 2019-$0.29-$0.59-$0.80 - -$0.23+50.85%BeatN/A13N/AOct 29, 2019$3.25B
    Jun 30, 2019-$0.47-$0.51-$0.94 - -$0.36+7.84%BeatN/A15N/AAug 5, 2019$3.30B
    Mar 31, 2019-$0.53-$0.45-$0.86 - -$0.20-17.78%Miss-507.7%16N/AApr 30, 2019$3.38B
    Dec 31, 2018-$0.42-$0.60-$0.71 - -$0.34+30.00%BeatN/A17N/AFeb 20, 2019$3.45B
    Sep 30, 2018-$1.64-$1.02-$1.30 - -$0.57-60.78%MissN/A17N/AOct 29, 2018$3.45B
    Jun 30, 2018-$0.01-$0.43-$0.61 - -$0.25+97.67%BeatN/A16N/AJul 26, 2018$3.56B
    Mar 31, 2018$0.13-$0.19-$0.47 - $0.32+168.42%Beat+62.5%17N/AMay 1, 2018$3.69B
    Dec 31, 2017-$0.25-$0.34-$0.63 - -$0.14+26.47%Beat-154.3%18N/AFeb 27, 2018$3.06B
    Sep 30, 2017-$0.77-$0.30-$0.79 - -$0.11-156.67%MissN/A16N/ANov 1, 2017$3.67B
    Jun 30, 2017-$0.25-$0.12-$0.29 - $0.19-108.33%Miss-377.8%20N/AAug 1, 2017$4.14B
    Mar 31, 2017$0.08$0.13N/A-38.46%Miss-70.4%N/AN/AMay 1, 2017$4.49B
    Dec 31, 2016$0.46$0.13N/A+253.85%BeatN/AN/AN/AFeb 20, 2017$2.31B
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $1.99, a profit after a loss of $1.03 per share the year before. It was $0.47 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$1.99N/A
    Dec 31, 2024-$1.03N/A
    Dec 31, 2023-$1.39N/A
    Dec 31, 2022-$1.40-157.6%
    Dec 31, 2021$2.43+507.5%
    Dec 31, 2020$0.40N/A
    Dec 31, 2019-$0.89N/A
    Dec 31, 2018-$1.94N/A
    Dec 31, 2017-$1.19-353.2%
    Dec 31, 2016$0.47N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 5,900 words across 11 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20265,86111
    2026Q2Jun 30, 20265,33711
    2026Q1Mar 31, 20264,0359
    2025Q4Dec 31, 20255,69111
    2025Q3Sep 30, 20254,51711
    2025Q2Jun 30, 20256,53511
    2025Q1Mar 31, 20255,2209
    2024Q4Dec 31, 20245,6179

    2026Q3 Earnings Call

    Opening remarks

    Anton Hie Vice President of Investor Relations Thank you, Rocco. Good morning, and welcome to Community Health Systems third quarter 2026 conference call. Joining me on today's call are Kevin Hammons, Chief Executive Officer, and Jason Johnson, Executive Vice President and Chief Financial Officer. Before we begin, I must remind everyone that this conference call may contain certain forward-looking statements, including all statements that do not relate solely to historical or current facts. These forward-looking statements are subject to a number of known and unknown risks, which are described in headings such as Risk Factors in our annual report on Form 10-K and other reports filed with or furnished to the SEC. Actual results may differ significantly from those expressed in any forward-looking statements in today's discussion. We do not intend to update any of these forward-looking statements. Yesterday afternoon, we issued a press release with our financial statements and definitions and calculations of adjusted EBITDA and adjusted EPS. We have also posted a supplemental slides presentation on our website. All calculations we discuss today will exclude gains or losses from early extinguishment of debt, impairment gains or losses on the sale of businesses, expense from government and other legal matters and related costs, expense from employee termination benefits and other restructuring charges, and business transformation costs. With that said, I will turn the call over to Kevin Hammons, Chief Executive Officer.

    Kevin Hammons Chief Executive Officer Thank you, Anton. Good morning, everyone, and thank you for joining our third quarter 2026 conference call and for your continued interest in CHS. I want to begin by expressing my sincere appreciation to our dedicated clinical and operational teams across all of our facilities. Their steadfast commitment enables us to advance our core vision, making the healthcare experience exceptional for our patients, our communities, and each other. Even with the dynamic operating landscape, shaped by shifting coverage dynamics and broader macroeconomic pressures, we are taking direct, proactive steps to fortify our competitive position. Our execution remains anchored in our core operational priorities: elevating clinical quality, enhancing the patient and physician experience, and strengthening our employee engagement. Building on the quality momentum we shared last quarter, including strong Leapfrog safety grades across our network, our facilities continue to deliver outstanding clinical outcomes. In the third quarter, we further reduced our severe sepsis and septic shock mortality rates and hospital-acquired infection metrics, continuing to outperform national benchmarks. This commitment to clinical excellence is not just an operational milestone. It directly positions CHS as the provider of choice in our communities, creating a distinct competitive advantage that positions us to expand market share as patient demand normalizes and to achieve sustainable growth into the future.

    Frequently Asked Questions About CYH

    When is Community Health Systems's next earnings date?

    Community Health Systems's next earnings report is expected for Feb 16, 2027.

    Did CYH beat earnings estimates last quarter?

    No. Community Health Systems reported EPS of -$0.48 for the quarter ended Sep 30, 2026, below the -$0.22 estimate by 118.18%.

    What EPS do analysts expect from CYH next quarter?

    The consensus EPS estimate for Community Health Systems for the quarter ending Dec 31, 2026 is -$0.02 from 10 analysts, with estimates from -$0.35 to $0.42.

    How often does CYH beat earnings estimates?

    Community Health Systems beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -77.86%.